Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Roche's CEO Warns Russia-Ukraine War Causing Problems For Multiple Sclerosis Trials
April 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
Briefs
News
From
Benzinga
COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook
April 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Earnings
Market News
Biotech
From
Benzinga
Does Eli Lilly's Future Depend on its Alzheimer's Drug?
April 23, 2022
Tickers
BIIB
LLY
RHHBY
Tags
Market News
Recent Press Releases
RHHBY
From
Motley Fool
EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs
April 22, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
European Medicines Agency
Market News
Biotech
From
Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Tickers
ALNY
AMGN
AZN
BIIB
Tags
RHHBY
LLY
NOVO
From
InvestorPlace
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
April 20, 2022
Tickers
A
ILMN
MYGN
NTRA
Tags
Health Care
RHHVF
RHHBY
From
Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
Tickers
AZN
BNTX
DNLI
GSK
Tags
Stocks to Buy
DNLI
GSK
From
InvestorPlace
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
April 15, 2022
Tickers
HPQ
IBM
ILMN
MSFT
Tags
News
TSLA
Benzinga
From
Benzinga
FDA Extends Review Period For Regeneron's COVID-19 Antibody Therapy
April 14, 2022
Tickers
REGN
RHHBY
Tags
REGN
Health Care
Biotech
From
Benzinga
Volume Springs Back Into The OTC Markets In March – Take A Look At Some Of The Top Movers
April 14, 2022
Tickers
ABML
ADDYY
BNPQY
CLNV
Tags
Partner Content
Market News
TSCDY
From
Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
April 13, 2022
Tickers
PLRX
RHHBF
RHHBY
RHHVF
Tags
Biotech
Market News
RHHBF
From
Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
April 13, 2022
Tickers
AFMD
ALZN
ATRS
CRDF
Tags
Trading Ideas
AFMD
CRNX
From
Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
Tickers
BNTX
GMAB
MTNB
PFE
Tags
Biotech
Partner Content
PFE
From
Benzinga
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Tickers
AZN
BIIB
ENTX
GLSI
Tags
GLSI
Market News
Market Insight, Financial Articles
From
InvestorPlace
SoftBank Loses Vision Fund Leader; Continues To Liquidate Portfolio
April 04, 2022
Tickers
RHHBY
SFTBF
SFTBY
TECH
Tags
Briefs
News
Media
From
Benzinga
Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis
April 04, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Market News
RHHBF
From
Benzinga
FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults
April 04, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
RHHVF
RHHBY
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
LLY
ALNY
FDA
From
Benzinga
Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial
March 30, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Benzinga
General
Phase 3 Trial
From
Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
March 30, 2022
Tickers
ADGI
ADMP
AFMD
AMLX
Tags
BIOC
RHHBY
SGIOY
From
Benzinga
Drug makers, Scientists Working For Long COVID Treatments: Reuters
March 25, 2022
Tickers
AXLA
GSK
HGEN
MRNA
Tags
RHHBF
GSK
Market News
From
Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
Tickers
ANTX
ATHA
BMY
CODX
Tags
PNT
ELDN
ATHA
From
Benzinga
Why Are ImmunoGen Shares Trading Lower Today
March 21, 2022
Tickers
IMGN
RHHBY
Tags
Ovarian Cancer
Downgrades
Trading Ideas
From
Benzinga
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
March 16, 2022
Tickers
PTCT
RHHBF
RHHBY
RHHVF
Tags
RHHBY
RHHVF
Health Care
From
Benzinga
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
NVS
RHHBY
VIVO
From
Motley Fool
The OTCQX's Top 10 Experience A Shuffle In February
March 15, 2022
Tickers
ADDYY
ETHE
GBOOY
GBTC
Tags
JMSB
Markets
ZURVY
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
ANAB
Earnings
BAYRY
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
Benzinga
General
BAYZF
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Health Care
Biotech
Market News
From
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Tickers
ACIU
ADAP
ALDX
ALEC
Tags
TCON
INAB
ATNX
From
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.